Shares of Corbus Pharmaceuticals Holdings Inc. CRBP rose 2.35% to $6.10 Tuesday, on what proved to be an all-around positive ...
The team is on solid footing, but its approach doesn’t distinguish it from peers. Our research team assigns Neutral ratings to strategies they’re not confident will outperform a relevant index ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback